As pandemic lingers, more nurses consider leaving their jobs, survey finds
Roughly a third of nurses surveyed by McKinsey said they’re considering quitting their jobs. That’s up from 22% in a poll conducted last February.
Roughly a third of nurses surveyed by McKinsey said they’re considering quitting their jobs. That’s up from 22% in a poll conducted last February.
Ascension’s operating margin in the first six months of its fiscal year fell to 0.2% from 5.7% the year prior as it faced a host of challenges.
More ambulance trips are billing for “advanced life support,” denoting a higher level of care (and reimbursement) than basic life support services. Private insurers’ average payments for those trips increased 56% between 2017 and 2020.
Regulators allege a union between Lifespan and Care New England would increase prices and diminish quality as the combined system would control at least 70% of the state’s hospital market.
An election to decertify the Massachusetts Nurses Association from representing nurses at the hospital could threaten gains achieved in a new contract agreement following a 10-month strike last year.
Numerous pharmacists urged commissioners to probe the practices of PBMs, which they allege harm their independent pharmacies and threaten to drive them out of business.
Bakul Patel, the Center for Devices and Radiological Health’s chief digital health officer, will help FDA meet its 2022-2025 strategic priorities and set regulatory policies for the new technologies such as AI and machine learning.
The decision vacates a violation letter HHS sent to the drugmaker that argued it was illegally restricting discounts on drugs providers delivered through contract pharmacies.
It’s the latest sprint in an ongoing race among drugstore chains to build out nationwide medical clinics, as consumers increasingly look for low-cost, convenient care options close to the home after two years of the pandemic.
The agency’s four commissioners will weigh whether to investigate PBMs and their relationship to drug prices and “practices that may disadvantage independent or specialty pharmacies,” according to the meeting agenda.